Altox

Database / API & reference standards

API & reference standards

2-(1H-Indazol-4-yl)-6-[(4-(methylsulfonyl)-1-piperazinyl)methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine Methanesulfonate

2-(1H-Indazol-4-yl)-6-[(4-(methylsulfonyl)-1-piperazinyl)methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine Methanesulfonate is listed in the API and reference-standard collection under CAS 957054-33-0. Its represented structure has formula C25H35N7O9S4 and a calculated molecular weight of 705.86 g/mol.

2D chemical structure

S O O N N N N H N N N O S S O O O H S O O O H

Chemical identity

Catalog name
2-(1H-Indazol-4-yl)-6-[(4-(methylsulfonyl)-1-piperazinyl)methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine Methanesulfonate
Common name
Not available
Chemical name
4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine;methanesulfonic acid
CAS
957054-33-0
SMILES
CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1.CS(=O)(=O)O.CS(=O)(=O)O
InChI
InChI=1S/C23H27N7O3S2.2CH4O3S/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19;2*1-5(2,3)4/h2-4,13-14H,5-12,15H2,1H3,(H,24,27);2*1H3,(H,2,3,4)
InChIKey
RFRIKACSFOTIMU-UHFFFAOYSA-N
Associated API
GDC-0941 Bimesylate

Record ID: A713d5559e1ee

Computed properties

C25H35N7O9S4 Molecular formula
705.863 g/molMolecular weight
705.1379 DaMonoisotopic exact mass
216.29 ŲTopological polar surface area
1.1564 Calculated LogP (Wildman–Crippen)
172.1737 cm³/molMolar refractivity (Wildman–Crippen)
13 countHydrogen-bond acceptors
3 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. The SMILES contains 3 disconnected components. Calculations retain all represented components.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 4 8 12 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O S 0 8 16 24 32 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight705.86395.13
Calculated LogP (Wildman–Crippen)1.156427.70
Topological polar surface area216.2996.39
Hydrogen-bond acceptors1396.65
Hydrogen-bond donors381.39
Rotatable bonds (strict)560.59

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC25H35N7O9S4dimensionless
Molecular weight705.863g/mol
Monoisotopic exact mass705.1379Da
Topological polar surface area216.29Ų
Calculated LogP (Wildman–Crippen)1.1564dimensionless
Molar refractivity (Wildman–Crippen)172.1737cm³/mol
Hydrogen-bond acceptors13count
Hydrogen-bond donors3count
Rotatable bonds (strict)5count
Heavy atoms45count
Heteroatoms20count
Rings6count
Aromatic rings4count
Aliphatic rings2count
Saturated rings2count
Aromatic heterocycles3count
Aliphatic heterocycles2count
Saturated heterocycles2count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.48fraction
Formal charge0e
Disconnected components3count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area265.1191Ų
Valence electrons248count
Radical electrons0count
Bertz complexity1,902.537index
Balaban J0index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 2-(1H-Indazol-4-yl)-6-[(4-(methylsulfonyl)-1-piperazinyl)methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine Methanesulfonate

PDE, HBEL and impurity assessment for 2-(1H-Indazol-4-yl)-6-[(4-(methylsulfonyl)-1-piperazinyl)methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine Methanesulfonate

For a substance-specific assessment, request a PDE report for 2-(1H-Indazol-4-yl)-6-[(4-(methylsulfonyl)-1-piperazinyl)methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine Methanesulfonate or explore HBEL derivation for 2-(1H-Indazol-4-yl)-6-[(4-(methylsulfonyl)-1-piperazinyl)methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine Methanesulfonate. These services address exposure limits using toxicological evidence and the intended use of the substance.

For pharmaceutical development, explore prediction of degradation products of 2-(1H-Indazol-4-yl)-6-[(4-(methylsulfonyl)-1-piperazinyl)methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine Methanesulfonate and qualification of impurities related to 2-(1H-Indazol-4-yl)-6-[(4-(methylsulfonyl)-1-piperazinyl)methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine Methanesulfonate.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 2-(1H-Indazol-4-yl)-6-[(4-(methylsulfonyl)-1-piperazinyl)methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine Methanesulfonate

Explore Altox services and software through the Altox Pharma-Hub.